HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kazuhiro Yatera Selected Research

Occupational Air Pollutants

2/2022The Impact of Ambient Environmental and Occupational Pollution on Respiratory Diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kazuhiro Yatera Research Topics

Disease

36Pneumonia (Pneumonitis)
10/2022 - 07/2008
14Neoplasms (Cancer)
10/2022 - 03/2011
14Interstitial Lung Diseases (Interstitial Lung Disease)
01/2022 - 06/2002
12Lung Neoplasms (Lung Cancer)
02/2022 - 03/2014
10Idiopathic Pulmonary Fibrosis
11/2021 - 04/2016
9Inflammation (Inflammations)
01/2022 - 06/2002
9Infections
05/2021 - 01/2011
7Respiratory Insufficiency (Respiratory Failure)
06/2022 - 01/2011
7Communicable Diseases (Infectious Diseases)
02/2022 - 01/2013
7Asthma (Bronchial Asthma)
02/2022 - 09/2014
6Lung Diseases (Lung Disease)
02/2022 - 06/2011
6Respiratory Tract Infections (Respiratory Tract Infection)
11/2021 - 10/2011
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 07/2012
5Respiratory Tract Diseases (Respiratory Tract Disease)
02/2022 - 10/2011
5Rheumatoid Arthritis
01/2022 - 11/2008
5Pleural Effusion (Pleural Effusions)
01/2022 - 01/2014
5Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2022 - 01/2006
5Lung Injury
05/2021 - 01/2006
5Healthcare-Associated Pneumonia
05/2020 - 10/2013
4Pulmonary Emphysema
01/2022 - 01/2017
4Empyema
01/2022 - 01/2014
4Small Cell Lung Carcinoma (Small Cell Lung Cancer)
05/2021 - 03/2017
4Chronic Obstructive Pulmonary Disease (COPD)
05/2021 - 01/2019
4Human Influenza (Influenza)
01/2021 - 01/2011
4Pulmonary Hypertension
01/2020 - 01/2018
4Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
02/2018 - 01/2011
3Bacterial Pneumonia
04/2022 - 07/2014
3Malignant Mesothelioma
02/2022 - 11/2020
3Pneumoconiosis
02/2022 - 12/2002
3Dyspnea (Shortness of Breath)
01/2022 - 11/2008
3COVID-19
01/2022 - 01/2021
3Idiopathic Interstitial Pneumonias
01/2022 - 09/2011
3Lymphoma (Lymphomas)
01/2022 - 09/2013
3Hypoxia (Hypoxemia)
01/2020 - 01/2018
3Adenocarcinoma
01/2019 - 07/2015
3Cardiovascular Diseases (Cardiovascular Disease)
04/2018 - 08/2011
3Fibrosis (Cirrhosis)
12/2013 - 06/2002
2Heart Failure
10/2022 - 05/2021
2Hypersensitivity (Allergy)
01/2022 - 05/2021
2Pleurisy (Pleuritis)
01/2022 - 03/2011
2Tuberculosis (Tuberculoses)
01/2022 - 06/2014
2Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis)
01/2022 - 01/2021
2Invasive Pulmonary Aspergillosis
07/2021 - 10/2011
2Bronchiectasis
05/2021 - 07/2015
2Sinusitis
05/2021 - 04/2016
2Chronic Bronchitis
05/2021 - 01/2012
2Acute Lung Injury
03/2021 - 01/2017
2Renal Cell Carcinoma (Grawitz Tumor)
01/2021 - 01/2011
2Pulmonary Eosinophilia (Eosinophilic Pneumonia)
01/2021 - 01/2021

Drug/Important Bio-Agent (IBA)

1716S Ribosomal RNAIBA
10/2022 - 02/2009
17Adrenal Cortex Hormones (Corticosteroids)IBA
07/2022 - 01/2011
8Pharmaceutical PreparationsIBA
05/2021 - 06/2012
8Biomarkers (Surrogate Marker)IBA
04/2021 - 06/2002
7Anti-Bacterial Agents (Antibiotics)IBA
11/2021 - 02/2014
6Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2022 - 07/2008
6Prednisolone (Predate)FDA LinkGeneric
01/2022 - 09/2011
6Clarithromycin (Biaxin)FDA LinkGeneric
01/2021 - 01/2012
5Immunosuppressive Agents (Immunosuppressants)IBA
06/2022 - 09/2015
5Particulate MatterIBA
02/2022 - 02/2008
5Nitric Oxide Synthase (NO Synthase)IBA
01/2022 - 08/2014
5AntibodiesIBA
01/2022 - 10/2011
5Protein Isoforms (Isoforms)IBA
11/2021 - 08/2014
5CytokinesIBA
01/2021 - 06/2002
5MacrolidesIBA
01/2021 - 01/2012
4AnticoagulantsIBA
07/2022 - 06/2016
4AsbestosIBA
02/2022 - 02/2008
4Immune Checkpoint InhibitorsIBA
01/2021 - 01/2018
4Oxygen (Dioxygen)IBA
01/2021 - 01/2011
4Biological ProductsIBA
04/2018 - 01/2013
3Silicon Dioxide (Silica)FDA LinkGeneric
02/2022 - 10/2011
3SmokeIBA
02/2022 - 01/2019
3nintedanibIBA
11/2021 - 01/2017
3Carboplatin (JM8)FDA LinkGeneric
05/2021 - 03/2014
3SteroidsIBA
01/2021 - 04/2004
3NivolumabIBA
01/2021 - 01/2018
3InterleukinsIBA
01/2021 - 07/2008
3pembrolizumabIBA
01/2020 - 01/2018
3Bleomycin (Blenoxane)FDA LinkGeneric
12/2019 - 01/2006
3Immunoglobulin G (IgG)IBA
01/2018 - 06/2011
3Azithromycin (Zithromax)FDA LinkGeneric
06/2014 - 01/2012
2CollagenIBA
01/2022 - 07/2015
2Organic Chemicals (Chemicals, Organic)IBA
01/2022 - 01/2021
2Dexamethasone (Maxidex)FDA LinkGeneric
01/2022 - 03/2014
2PolymersIBA
01/2022 - 01/2021
2acrylic acid (acrylate)IBA
01/2022 - 01/2021
2Serpentine Asbestos (Chrysotile)IBA
01/2022 - 02/2008
2Immunoglobulins (Immunoglobulin)IBA
01/2022 - 01/2021
2CateninsIBA
11/2021 - 04/2016
2pirfenidoneIBA
11/2021 - 01/2021
2RNA (Ribonucleic Acid)IBA
11/2021 - 03/2020
2liposomal amphotericin BFDA Link
07/2021 - 10/2011
2Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA
04/2021 - 11/2016
2IpilimumabIBA
01/2021 - 06/2018
2Methotrexate (Mexate)FDA LinkGeneric
01/2021 - 01/2019
2Anti-Infective Agents (Microbicides)IBA
01/2021 - 07/2014

Therapy/Procedure

20Therapeutics
07/2022 - 04/2004
8Drug Therapy (Chemotherapy)
01/2022 - 03/2011
2Activities of Daily Living (ADL)
10/2022 - 01/2022
2Artificial Respiration (Mechanical Ventilation)
10/2022 - 09/2011
2Pneumonectomy (Lung Volume Reduction)
01/2022 - 12/2017